Gust H. Bardy

Active 1974–2020

Also published as
GUST H. BARDY · Gust H Bardy
57
Papers
18,146
Citations
52
h-index
56
i10-index

Citations

Citations per year for Gust H. Bardy1964: 1 citations1972: 1 citations1974: 1 citations1982: 1 citations1983: 4 citations1984: 7 citations1985: 5 citations1986: 6 citations1987: 8 citations1988: 11 citations1989: 17 citations1990: 8 citations1991: 24 citations1992: 20 citations1993: 35 citations1994: 28 citations1995: 42 citations1996: 34 citations1997: 21 citations1998: 41 citations1999: 33 citations2000: 35 citations2001: 51 citations2002: 31 citations2003: 53 citations2004: 28 citations2005: 85 citations2006: 135 citations2007: 83 citations2008: 114 citations2009: 119 citations2010: 144 citations2011: 104 citations2012: 122 citations2013: 93 citations2014: 104 citations2015: 128 citations2016: 81 citations2017: 105 citations2018: 59 citations2019: 238 citations2020: 197 citations2021: 183 citations2022: 155 citations2023: 96 citations2024: 164 citations2025: 79 citations1965–1971: no citations, so these years are not shown1973: no citations, so this year is not shown1975–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,381 citing papers, 30.2% of this breakdownUnited Kingdom: 371 citing papers, 8.1% of this breakdownGermany: 287 citing papers, 6.3% of this breakdownItaly: 260 citing papers, 5.7% of this breakdownNetherlands: 260 citing papers, 5.7% of this breakdownCanada: 241 citing papers, 5.3% of this breakdownFrance: 160 citing papers, 3.5% of this breakdownAustralia: 130 citing papers, 2.8% of this breakdownDenmark: 112 citing papers, 2.4% of this breakdownSpain: 104 citing papers, 2.3% of this breakdownJapan: 104 citing papers, 2.3% of this breakdownSweden: 91 citing papers, 2% of this breakdown
0%30.2%Other 23.4%

Fields

  • Medicine93.5%
  • Biochemistry, Genetics and Molecular Biology2.1%
  • Engineering1.9%
  • Neuroscience0.8%
  • Computer Science0.4%
  • Economics, Econometrics and Finance0.3%
  • Other1%

Topics

  • Cardiac pacing and defibrillation studies16.9%
  • Cardiac electrophysiology and arrhythmias12.3%
  • Cardiac Arrhythmias and Treatments10%
  • Atrial Fibrillation Management and Outcomes5.2%
  • Cardiovascular Function and Risk Factors4.7%
  • Heart Failure Treatment and Management4.4%
  • Other46.5%

Coauthors

All papers

Open in search
  1. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 6,526

  2. Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,456

  3. An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 774

  4. Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,040

  5. Thyroid Function in Heart Failure and Impact on Mortality

    Authors: , , , , , , , - JACC Heart Failure 2013 cited by 138

  6. Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities

    Authors: , , , , , , , , , , , , , , , , , - JACC Heart Failure 2014 cited by 96

  7. Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 88

  8. Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized Trials

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Kidney Diseases 2014 cited by 109

  9. Catheter Technique for Closed-Chest Ablation of the Atrioventricular Conduction System

    Authors: , , , , , , - New England Journal of Medicine 1982 cited by 770

  10. Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial

    Authors: , , , , , , , , - Journal of Cardiovascular Electrophysiology 2008 cited by 86

  11. Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure

    Authors: , , , , , , , - New England Journal of Medicine 2008 cited by 261

  12. Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2009 cited by 244

  13. Tripling Survival From Sudden Cardiac Arrest Via Early Defibrillation Without Traditional Education in Cardiopulmonary Resuscitation

    Authors: , , , , , - Circulation 2002 cited by 318

  14. Home Use of Automated External Defibrillators for Sudden Cardiac Arrest

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 302

  15. Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy

    Authors: , , , , , , , , , , , , , , , , , , , - American Heart Journal 2012 cited by 168

  16. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis

    Authors: , , , , - EP Europace 2010 cited by 161

  17. Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population

    Authors: , , , , , , , , , , , , , - Circulation 2009 cited by 221

  18. Wide Complex Tachycardia: Misdiagnosis and Outcome After Emergent Therapy

    Authors: , , - Annals of Internal Medicine 1986 cited by 261

  19. Multicenter Comparison of Truncated Biphasic Shocks and Standard Damped Sine Wave Monophasic Shocks for Transthoracic Ventricular Defibrillation

    Authors: , , , , , , , , , , , , , , , - Circulation 1996 cited by 208

  20. Low‐Energy Impedance‐Compensating Biphasic Waveforms Terminate Ventricular Fibrillation at High Rates in Victims of Out‐of‐Hospital Cardiac Arrest

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Cardiovascular Electrophysiology 1997 cited by 133

  21. Dynamic Pressure–Flow Velocity Relationships in the Human Cerebral Circulation

    Authors: , , , , - Stroke 2003 cited by 129

  22. Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients

    Authors: , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Quality and Outcomes 2015 cited by 106

  23. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy

    Authors: , , , , , , , , - JAMA Cardiology 2017 cited by 99

  24. Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillator. The LIFE Investigators.

    Authors: , , , , , , , , , , - 1999 cited by 98